Welcome to the START Center for Cancer Research. We are a global leader in cancer research, dedicated to the relentless pursuit of hope for patients and their families.
We believe that every patient should have the opportunity to access clinical trials, regardless of where they receive their cancer treatment.
100,000+ square feet of world-class research facilities
Stay up to date with everything at START, from blog insights and press and newsroom updates to expert-led webinars and much more.
Discover how XenoSTART’s clinic-to-bench pipeline delivers more clinically relevant PDX models, real-world patient data, and accelerated drug development. Patient-derived xenograft
Read more →
“I was thinking about this the other night, one of the things that changed was I stopped flossing, because I
A recent START webinar titled Malignant Hematology: Advancing Treatment in Blood Cancers, provided an in-depth look into the current advancements
Antibody-drug conjugates (ADCs) are among the most promising innovations in cancer treatment today, combining the targeting precision of monoclonal antibodies
The integration of wearable technology into early-phase cancer trials represents a pivotal moment in oncology research, offering the ability to
Randomized clinical trials (RCTs) began in the 1940s with streptomycin’s evaluation against tuberculosis. Since then, RCTs have been the foundation